The Altissimo Study using a TKI for nAMD
Retina Synthesis - A podcast by Retina Synthesis
Categories:
We review the results of the phase I Graybug study Altissimo using sustained release tyrosinase kinase inhibitor for long term treatment of neovascular AMD with Dr. Veeral Sheth, Chicago, Illinois, Assistant Clinical Professor University of Illinois at Chicago.
